Vitrolife launch a new generation of Growth Factors and Cytokines for cultivation of stem cells The world's first biorisk-free growth factors and cytokines products. Manufactured in barley grain, the products are xeno-free, serum-free, endotoxin-free and present a new option for stem cell cultivation. Through the signing of a Distribution and Supply Agreement, Vitrolife secures worldwide rights to distribute, market and sell the Growth factors and Cytokines produced in plants by ORF Genetics for cell culture media. These new products are the world's first biorisk-free growth factors and cytokines. Manufactured in barley grain, the products are xeno-free, serum-free, endotoxin-free and present a new option for stem cell cultivation. “Patient safety is with us all the way - from development to the final product, says Anna Mårtensson, Head of the Stem Cell business area at Vitrolife. By using barley grain and bypassing the use of bacterial or animal systems these products are contributing to a higher patient safety and in addition, the stem cell therapy companies can enjoy an easier regulatory clearance. These new growth factors and cytokines are therefore fully in-line with our focus on providing researchers and cell therapy companies high quality media, reagents and instruments that will facilitate their use of stem cells for therapeutic purposes.” October 1, 2010 Gothenburg Magnus Nilsson CEO Queries should be addressed to: Magnus Nilsson, CEO, phone +46 31 721 80 61 Anne-Lie Sveder, CFO, phone +46 31 721 80 13
Vitrolife launch a new generation of Growth Factors and Cytokines for cultivation of stem cells
| Source: Vitrolife AB